Reneo Pharmaceuticals CEO Gregory Flesher's 2021 pay jumps 3,939% to $5.4M
Reneo Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 22, 2022
Reneo Pharmaceuticals reported fiscal year 2021 executive compensation information on April 22, 2022.
In 2021, three executives at Reneo Pharmaceuticals received on average a compensation package of $3M, a 2,119% increase compared to previous year.
Average pay of disclosed executives at Reneo Pharmaceuticals
Gregory J. Flesher, Chief Executive Officer, received $5.4M in total, which increased by 3,939% compared to 2020. 78% of Flesher's compensation, or $4.2M, was in option awards. Flesher also received $220K in non-equity incentive plan, $475K in salary, $430K in stock awards, as well as $48K in other compensation.
Vineet R. Jindal, Chief Financial Officer, received a compensation package of $2M. 71% of the compensation package, or $1.4M, was in option awards.
Michael P. Cruse, Chief Operating Officer, earned $1.5M in 2021.
Related executives
You may also like
Source: SEC filing on April 22, 2022.